 |
|
A new mechanism regulates type I interferon production in white blood cells
January 13, 2009A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production. This discovery, co-authored by scientists from the International Medical Center of Japan (Tokyo), the National Cancer Institute at Frederick (Maryland) and the McGill Centre for the Study of Host Resistance, was published on December 22, 2008 in the Journal of Experimental Medicine.
The plasmacytoid dendritic cell (pDC) is a type of white blood cell. The primary function of this cell type is to produce type I interferon when the body is infected by a virus. The pDC has special surface receptors that can detect many types of viruses. Type I interferon is thus very important for the clearance of a viral infection. "Working with mice, we have identified a mechanism that regulates the amount of interferon that is produced by pDCs, explains Dr. Makrigiannis. That mechanism is a protein-protein interaction between surface receptor Ly49Q and the class I major histocompatibility complex (MHC) molecule."
It is known that viruses often cause a decrease of class I MHC molecules on cells. The team of scientists believes that the reason for this may be to stop interferon production by the pDCs. Thus, class I MHC recognition by Ly49Q on pDCs is necessary for the optimal activation of innate immune responses in vivo.
The discovery of this molecular strategy will very likely have a great impact in virology, and could eventually help physicians develop better therapeutic strategies to fight the infectious diseases afflicting their patients.
Institut de recherches cliniques de Montreal
The discovery of this molecular strategy will very likely have a great impact in virology, and could eventually help physicians develop better therapeutic strategies to fight the infectious diseases afflicting their patients.
Institut de recherches cliniques de Montreal
Interferon Production Current Events and Interferon Production News RSSStem cells: Deathly awakening by interferon
After injuries with blood loss, the body quickly needs to restore the vital blood volume. This is accomplished by a special group of stem cells in the bone marrow.
Genetic breakthrough supercharges immunity to flu and other viruses
Researchers at McGill University have discovered a way to boost an organism's natural anti-virus defences, effectively making its cells immune to influenza and other viruses.
NEJM editorial on significance and limitations of new lupus gene expression research
Some 1.5 million Americans, most of them women, suffer from lupus, a disease where the person's immune system attacks the body's own tissue.
Molecular 'on/off switch' controls immune defenses against viruses
Much like flipping a light switch, the hepatitis C virus turns on human immune defenses upon entering the body but also turns off those defenses by manipulating interaction of key cellular proteins, UT Southwestern Medical Center researchers have found.
Study details hepatitis C ability to block immune system response
Hepatitis C virus (HCV) is a worldwide public health problem. The World Health Organization estimates that 170 million people worldwide are chronically infected and that between 3-4 million are newly infected annually.
Sounding the alarm for infections: EMBL researchers discover rapid-response, interferon-producing cells
Nearly fifty years ago, researchers discovered that when cells in laboratory cultures are infected by a virus, they secrete a substance that protects other cells from infection. In 1957 Alick Issaks and Jean-Jacques Lindenmann traced this effect to a protein called interferon, a molecule now known to play a key role in the immune system. Human and animal cells produce it in a rapid "first wave" response to infections. Since its discovery, scientists have sought to use this natural substance to cure all sorts diseases, and clinical trials have demonstrated interferon's potential to combat diseases as different as hepatitis C, blood cancers, and multiple sclerosis. Yet many aspects of
More Interferon Production Current Events and Interferon Production News Articles
| © 2009 BrightSurf.com |